The Infectious Diseases Diagnostics Market will witness a CAGR of 7.9% by reaching US$ 1503.8 Million from 2024. The new-fangled healthcare electronic technologies like 3D printing, GPS tracking, and wearable biometric devices are being tested concerning clinical use. Cutting-edge technology is expected to be one of the driving forces in the healthcare industry in the subsequent decade.

According to the latest market report published by Persistence Market Research, titled “Global Market Study on Infectious Diseases Diagnostics: Increasing Demand for Evidence-Based Treatment to Boost Demand for Infectious Diagnostic Testing during Forecast Period”. The global market for infectious diseases diagnostics is estimated to reach US$ 876.6 Mn in 2016 from US$ 827.7 Mn in 2015 owing to increasing demand for diagnostic kits caused by rising incidence rate of infectious diseases.

The global infectious disease diagnostics market is expected to reach US$ 1503.8 Mn by 2024. Sexually Transmitted Diseases (STDs) segment is expected to continue to remain the largest segment by diseases indication accounting for US$ 282.4 Mn in terms of revenue in 2016, a Y – o – Y increase of 7.0% over 2015. The chlamydia diagnostics test kits are expected to gain upward momentum in 2016, growing at 8.9% in terms of revenue, the fastest among disease indication segment.

Planning Forward? Access Sample Of Infectious Diseases Diagnostics Market Report! https://www.persistencemarketresearch.co/samples/11413

Company Profiled

  • Becton Dickinson & Company
  • Cepheid, Inc.
  • Abbott Laboratories
  • bioMerieux SA
  • Hologic, Inc.
  • Danaher Corporation
  • Thermo Fisher Scientific, Inc.
  • Roche Diagnostics
  • Alera Inc.
  • DiaSorin S.p.A.
  • Quidel Corporation
  • Bio-Rad Laboratories, Inc.

How About Revitalizing The Strategy-Oriented Funnel To Stay Ahead In The Infectious Diseases Diagnostics Market? https://www.persistencemarketresearch.co/methodology/11413

Cell cultures segment is expected to register highest CAGR in terms of revenue, by test type accounting for US$ 311.4 Mn in terms of revenue in 2016. The affordability of cell culture kits and large applications in diagnosis of several infectious diseases is gaining traction. Consumption demand for cell culture test kits will witness a growth rate of 7.2 % in 2016 over 2015.

Diagnostic centers end user segment is expected to register highest CAGR in terms of revenue, accounting for US$ 392.8 Mn in terms of revenue in 2016. The increasing number of diagnostics centers, worldwide and a large number of patient pool depending on diagnostics centers for diagnosis of infectious diseases is expected to increase demand for diagnostics tests among diagnostics centers. The diagnostics centers end user segment will witness a growth rate of 7.4 % in 2016 over 2015.

Planning To Introduce An Offbeat Product/Technology In The Infectious Diseases Diagnostics Market? Go To “Purchase Now” To Have Our Infectious Diseases Diagnostics Market Report! https://www.persistencemarketresearch.com/checkout/11413

Becton, Dickinson and Company, Cepheid, Inc. Abbott Laboratories, bioMérieux SA, Hologic, Inc., Danaher Corporation, Thermo Fisher Scientific Inc., Roche Diagnostics, Alere Inc., DiaSorin S.p.A., Quidel Corporation, and Bio-Rad Laboratories, Inc. are key players in the market. Top players are focusing on developing new products and improving sensitivity and specificity of the test kits. Collaborations and joint ventures among manufacturers and local governments are key business strategies being adopted to increase market share.

Access Trending Reports:

Medical Marijuana Market – The medical marijuana market is anticipated to record a year-over-year growth rate of 15.9% and reach a market value of US$ 39,891.2 Mn by 2026. 

Dural Graft Market – Persistence Market Research predicts that, the global dural graft market will exhibit a 6% CAGR during the forecast period (2019-2029).

Diagnostic Imaging Devices Market – The global diagnostic imaging devices market was valued at USD 26,477.1 million in 2014 and is expected to grow at a CAGR of 5.2% from 2014 to 2020, to reach an estimated value of USD 35,793.4 million in 2020.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

Tags: Infectious Diseases Diagnostics Market Demand, Infectious Diseases Diagnostics Market Analysis, Infectious Diseases Diagnostics Market Development, Infectious Diseases Diagnostics Market Forecast, Infectious Diseases Diagnostics Market Revenue Share

See Campaign: https://www.persistencemarketresearch.com/market-research/infectious-diseases-diagnostics-market.asp
Contact Information:
Persistence Market Research Address – 305 Broadway, 7th Floor, New York City, NY 10007, United States U.S. Ph. – +1-646-568-7751 USA-Canada Toll-free – +1 800-961-0353

Tags:
Menafn, Reportedtimes, PR-Wirein, iCN Internal Distribution, Extended Distribution, Research Newswire, English